Actively Recruiting
Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis
Led by University of Maryland, Baltimore · Updated on 2025-07-28
68
Participants Needed
1
Research Sites
212 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
People with psychotic disorders are excluded from most suicide-focused clinical trials despite incredibly high rates of completed suicide, and interventions that have been tested for this population have shown limited impact on suicide. Emotion dysregulation is a significant suicidogenic factor that is understudied in people with psychotic disorders. The investigators propose to implement and evaluate an intervention targeting emotion dysregulation in people with psychotic disorders while employing rigorous statistical modeling and measurement techniques including Ecological Momentary Assessment, which will support future advanced research on suicide and suicide prevention for this high-risk group.
CONDITIONS
Official Title
Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18 years old
- Diagnosed with a psychosis spectrum disorder assessed by the Mini International Neuropsychiatric Interview (MINI)
- Heightened suicide risk with a score of 8 or higher on the Suicide Behaviors Questionnaire-Revised (SBQ-R)
- Enrolled and engaged in outpatient mental health services with at least one service in the previous month
- Reading level equivalent to 6th grade or higher as assessed by the Wide Range Achievement Test 4 (WRAT-4)
You will not qualify if you...
- Diagnosis of intellectual disability (DSM5 317, 318)
- Diagnosis of traumatic brain injury
- Diagnosis of deafness
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Maryland
Baltimore, Maryland, United States, 21201
Actively Recruiting
Research Team
P
Peter L Phalen, PsyD'
CONTACT
W
Wendy Potts
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here